The new transformational (12 months) 36-credit Master’s Degree Program in Biopharmaceutical Process Engineering will be delivered at the Jefferson Institute for Bioprocessing (JIB) and is ideal for employment focused graduates with first degrees in Life Sciences and Engineering.

The Jefferson Institute for Bioprocessing (JIB) is a 25,000 sq. ft. state-of-the art facility designed for the training of industry professionals, as well as the education of the next generation of scientists and engineers interested in pursuing rewarding careers in biomanufacturing. Biopharmaceutical Processing is a rapidly growing industry focused on the development of robust processes to manufacture high value biologics and advanced therapeutics for patients with debilitating and life limiting diseases that affect millions of patients worldwide, such as cancer, rheumatoid arthritis, Alzheimer’s, and Parkinson’s.

Training and education in biopharmaceutical processing are exceptionally laboratory intensive. At JIB our students spend less time in traditional classroom settings and more time in JIB’s pilot-scale facility fully equipped with the most advanced technologies and processes used by industry to manufacture biopharmaceuticals.

For the hybrid option, the fall and spring schedule for courses requiring the completion of on-site hands-on laboratory related coursework will be available prior to the start of each respective semester. In each instance, the on-site coursework will be scheduled in continuous late-semester blocks to avoid the necessity of frequent travel.